Login / Signup

Low-dose IL-2 therapy compensates for metabolic shifts and reverses anxiety-like behavior in PD-1 deficiency-induced autoimmunity.

Cui LvHao ZhangZifa LiHao ZhangYu ZhangRonghui LiSheng WeiDi Yu
Published in: Cellular & molecular immunology (2020)
Keyphrases
  • low dose
  • high glucose
  • diabetic rats
  • high dose
  • replacement therapy
  • sleep quality
  • stem cells
  • oxidative stress
  • mesenchymal stem cells
  • physical activity
  • celiac disease
  • smoking cessation